Complete Filing Data
Estrella Immunopharma, Inc. reported Stockholders Equity of -$10.37 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Estrella Immunopharma, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | -$13.1M | -$7.3M | -$11.1M | -$996.1K | -$247.7K |
| Operating Income Loss | -$13.1M | -$7.3M | -$11.1M | -$1.6M | -$249.1K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$13.1M | -$7.3M | -$11.1M | -$915.5K | -$247.7K |
| Research And Development Expense | $10.2M | $4.1M | $10.5M | ||
| Operating Expenses | $13.1M | $7.3M | $11.1M | ||
| General And Administrative Expense | $2.8M | $3.2M | $663.2K | ||
| Income Tax Expense Benefit | $838.00 | $1.6K | $80.6K | $0.00 | |
| Income Loss From Continuing Operations Per Diluted Share | -$1.52 | ||||
| Income Loss From Continuing Operations Per Basic Share | -$1.52 | ||||
| Income Taxes Paid Net | $913.00 | $1.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$4.8M | -$5.5M | -$2.1M | -$3.4M | -$4.0M | -$469.5K | -$1.0M | -$1.9M | -$76.0K | -$2.7M | -$2.8M | -$2.9M | -$359.6K | -$141.3K | -$107.5K | -$3.6K | -$819.00 |
| Operating Income Loss | -$4.8M | -$5.5M | -$2.1M | -$3.4M | -$3.9M | -$469.5K | -$1.0M | -$1.9M | -$169.2K | -$2.7M | -$2.8M | -$2.9M | -$423.8K | -$144.9K | -$108.1K | -$3.6K | -$819.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$4.8M | -$5.5M | -$2.1M | -$3.4M | -$3.9M | -$469.5K | -$1.9M | -$54.9K | -$43.9K | -$344.9K | -$359.6K | -$141.3K | -$107.5K | -$3.6K | -$819.00 | ||
| Research And Development Expense | $4.2M | $4.7M | $1.4M | $2.8M | $3.5M | $25.0K | $75.5K | $483.5K | $2.6M | $2.6M | $2.6M | ||||||
| Operating Expenses | $4.8M | $5.5M | $2.1M | $3.4M | $3.9M | $469.5K | $1.0M | $1.9M | $2.7M | $2.8M | $2.9M | ||||||
| General And Administrative Expense | $648.5K | $883.7K | $694.1K | $550.7K | $424.4K | $444.5K | $945.2K | $1.4M | $117.7K | $148.4K | $280.3K | ||||||
| Income Tax Expense Benefit | $850.00 | $13.00 | $1.6K | $21.1K | $19.5K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Income Loss From Continuing Operations Per Diluted Share | -$0.99 | ||||||||||||||||
| Income Loss From Continuing Operations Per Basic Share | -$0.99 | ||||||||||||||||
| Income Taxes Paid Net | $13.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | -$10.4M | $143.7K | -$1.0M | $0.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.4M | $916.9K | $4.1M | |||
| Retained Earnings Accumulated Deficit | -$37.0M | -$23.9M | -$12.2M | -$1.0M | ||
| Common Stock Value | $3.8K | $3.7K | $98.00 | $142.00 | ||
| Cash And Cash Equivalents At Carrying Value | $1.4M | $916.9K | $2.5M | $478.9K | ||
| Liabilities Current | $13.5M | $3.0M | $9.8M | $73.2K | ||
| Liabilities And Stockholders Equity | $3.2M | $3.1M | $3.0M | $45.8M | ||
| Liabilities | $13.5M | $3.0M | $9.8M | $1.6M | ||
| Assets | $3.2M | $3.1M | $3.0M | $45.8M | ||
| Assets Current | $1.7M | $1.6M | $2.8M | $616.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $467.4K | $1.7M | -$1.6M | |||
| Treasury Stock Value Acquired Cost Method | $29.5K | $354.4K | ||||
| Accounts Payable And Other Accrued Liabilities Current | $238.4K | $201.8K | $398.8K | |||
| Treasury Stock Common Shares | 515.3K | 487.0K | 0.00 | |||
| Treasury Stock Value | $598.4K | $568.9K | ||||
| Franchise Tax Payable | $70.2K | |||||
| Prepaid Expense And Other Assets Current | $292.7K | $723.9K | ||||
| Temporary Equity Carrying Amount Attributable To Parent | $44.3M | |||||
| Taxes Payable Current | $50.00 | |||||
| Franchise Tax Payables Current | $4.1K | $4.3K | ||||
| Increase Decrease Franchise Tax Payable | $74.0K | $70.2K | ||||
| Gain Loss On Investments | $654.1K | $1.4K | ||||
| Deferred Underwriters Marketing Fees | $1.6M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$438.1K | $478.9K | ||||
| Assets Held In Trust Noncurrent | $45.2M | |||||
| Accounts Payable And Accrued Liabilities Current | $3.0K | |||||
| Temporary Equity Accretion To Redemption Value Adjustment | $253.4K | $4.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$9.8M | -$6.1M | -$1.8M | $746.3K | $8.5M | $9.0M | $10.1M | -$11.7M | -$9.1M | -$6.5M | -$3.8M | -$1.1M | -$1.0M | -$870.4K | $20.6K | $24.2K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.6M | $1.3M | $421.5K | $1.8M | $4.7M | $9.0M | $22.1M | $2.5M | $2.7M | $2.9M | $3.0M | $321.7K | $478.9K | $772.2K | $11.0K | $42.1K | ||
| Retained Earnings Accumulated Deficit | -$36.4M | -$31.6M | -$26.0M | -$22.9M | -$19.5M | -$15.5M | -$15.1M | -$14.1M | -$2.5M | -$2.3M | -$2.0M | -$1.5M | -$1.1M | -$870.5K | ||||
| Common Stock Value | $3.8K | $3.8K | $3.7K | $3.7K | $3.7K | $3.7K | $3.5K | $3.5K | $142.00 | $142.00 | $142.00 | $142.00 | $142.00 | $142.00 | ||||
| Cash And Cash Equivalents At Carrying Value | $1.6M | $1.3M | $421.5K | $1.8M | $4.2M | $4.7M | $9.0M | $22.1M | $29.4K | $40.8K | $73.8K | $88.3K | $321.7K | $321.7K | ||||
| Liabilities Current | $13.4M | $9.1M | $4.3M | $3.0M | $180.7K | $138.5K | $398.7K | $17.3M | $1.2M | $1.1M | $735.8K | $154.6K | $30.2K | $100.6K | ||||
| Liabilities And Stockholders Equity | $3.5M | $3.0M | $2.4M | $3.7M | $4.5M | $8.6M | $9.4M | $27.3M | $9.8M | $9.7M | $45.6M | $45.4M | $45.6M | $46.0M | ||||
| Liabilities | $13.4M | $9.1M | $4.3M | $3.0M | $180.7K | $138.5K | $398.7K | $17.3M | $2.8M | $2.7M | $2.3M | $1.7M | $1.6M | $1.7M | ||||
| Assets | $3.5M | $3.0M | $2.4M | $3.7M | $4.5M | $8.6M | $9.4M | $27.3M | $9.8M | $9.7M | $45.6M | $45.4M | $45.6M | $46.0M | ||||
| Assets Current | $2.0M | $1.5M | $944.3K | $2.2M | $4.5M | $8.6M | $9.4M | $81.9K | $52.4K | $160.8K | $128.8K | $428.1K | $780.1K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$495.4K | -$2.4M | -$4.3M | $19.7M | -$1.1M | |||||||||||||
| Treasury Stock Value Acquired Cost Method | $29.5K | $150.5K | $270.3K | $84.1K | ||||||||||||||
| Accounts Payable And Other Accrued Liabilities Current | $75.6K | $110.8K | $117.8K | $189.0K | $131.8K | $89.4K | $270.6K | |||||||||||
| Treasury Stock Common Shares | 515.3K | 515.3K | 515.3K | 431.7K | 321.8K | 74.9K | ||||||||||||
| Treasury Stock Value | $598.4K | $598.4K | $598.4K | $504.9K | $354.4K | $84.1K | ||||||||||||
| Franchise Tax Payable | $200.00 | $13.1K | $144.1K | $30.7K | $48.2K | $24.2K | $97.6K | |||||||||||
| Prepaid Expense And Other Assets Current | $396.9K | $163.9K | $522.8K | $437.6K | $288.8K | |||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $9.8M | $9.5M | $9.3M | $45.3M | $45.2M | $45.2M | $45.2M | $45.2M | ||||||||||
| Taxes Payable Current | $50.00 | $40.7K | $40.7K | $40.7K | $40.7K | $61.6K | $51.2K | |||||||||||
| Franchise Tax Payables Current | $4.1K | $4.1K | $4.4K | $4.4K | ||||||||||||||
| Increase Decrease Franchise Tax Payable | -$131.0K | -$46.0K | ||||||||||||||||
| Gain Loss On Investments | $114.3K | $105.8K | $204.3K | $64.2K | $3.7K | $567.00 | $4.00 | |||||||||||
| Deferred Underwriters Marketing Fees | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$11.4K | -$157.1K | $42.1K | |||||||||||||||
| Assets Held In Trust Noncurrent | $9.8M | $9.7M | $9.7M | $45.5M | $45.3M | $45.2M | $45.2M | |||||||||||
| Accounts Payable And Accrued Liabilities Current | $437.8K | $375.0K | $329.2K | $206.5K | $106.4K | $6.0K | $3.0K | |||||||||||
| Temporary Equity Accretion To Redemption Value Adjustment | $209.7K | $129.6K | $4.6M | $4.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.8M | -$16.1M | -$1.3M | -$1.0M | -$316.2K |
| Net Cash Provided By Used In Financing Activities | $2.3M | $12.8M | -$35.6M | $46.0M | |
| Share Based Compensation | $619.0K | $1.2M | $409.6K | ||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $36.7K | -$450.0K | $122.6K | ||
| Increase Decrease In Accrued Liabilities | $9.6M | -$18.0K | $22.0K | ||
| Increase Decrease In Accounts Payable Related Parties | $550.3K | -$9.3M | $8.4M | ||
| Net Cash Provided By Used In Investing Activities | $5.0M | -$273.1K | $36.2M | -$45.2M | |
| Increase Decrease In Accrued Income Taxes Payable | -$50.00 | -$138.00 | $3.2K | $51.2K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$431.2K | $150.0K | |||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $619.0K | ||||
| Proceeds From Issuance Of Common Stock | $2.4M | $25.0K | |||
| Payments Of Stock Issuance Costs | $117.5K | $1.5M | $580.0K | ||
| Increase Decrease In Prepaid Expenses Other | -$833.3K | ||||
| Increase Decrease In Prepaid Expense | -$125.5K | $137.2K | |||
| Increase Decrease In Franchise Tax Payable | -$4.1K | ||||
| Proceeds From Related Party Debt | $0.00 | $300.0K | |||
| Payments For Repurchase Of Other Equity | $354.4K | ||||
| Payments For Repurchase Of Equity | $29.5K | ||||
| Proceeds From Business Combination | $726.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q1 2024 | Q3 2023 | Q1 2023 | Q3 2022 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$466.0K | -$2.2M | -$4.2M | -$275.2K | -$275.7K | -$1.1M | -$157.1K | -$819.00 | ||
| Net Cash Provided By Used In Financing Activities | -$29.5K | -$150.5K | -$84.1K | $20.0M | $186.5K | $42.9K | ||||
| Share Based Compensation | $152.4K | $159.1K | $159.1K | $1.2M | $102.4K | |||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$83.9K | $57.2K | -$181.2K | $394.8K | $66.1K | |||||
| Increase Decrease In Accrued Liabilities | $1.4M | $2.7M | -$2.0K | $2.0K | ||||||
| Increase Decrease In Accounts Payable Related Parties | $9.6K | $5.0K | -$77.1K | $4.5K | $782.2K | |||||
| Net Cash Provided By Used In Investing Activities | -$112.3K | $77.8K | ||||||||
| Increase Decrease In Accrued Income Taxes Payable | -$612.00 | $41.2K | $800.00 | |||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$201.1K | $148.9K | $4.9K | |||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $152.4K | $159.1K | $159.1K | |||||||
| Proceeds From Issuance Of Common Stock | $25.0K | |||||||||
| Payments Of Stock Issuance Costs | $182.1K | |||||||||
| Increase Decrease In Prepaid Expenses Other | $1.5M | $3.5M | -$833.3K | |||||||
| Increase Decrease In Prepaid Expense | $40.9K | -$30.8K | ||||||||
| Increase Decrease In Franchise Tax Payable | -$4.1K | -$612.00 | ||||||||
| Proceeds From Related Party Debt | $136.5K | $200.0K | ||||||||
| Payments For Repurchase Of Other Equity | $150.5K | |||||||||
| Payments For Repurchase Of Equity | $29.5K | $84.1K | ||||||||
| Proceeds From Business Combination | $726.3K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2021 |
|---|---|---|---|---|
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 36.8M | 27.1M | 305.7K | 1.2M |
| Weighted Average Number Of Diluted Shares Outstanding | 36.8M | 27.1M | 305.7K | 1.2M |
| Earnings Per Share Diluted | $-0.35 | $-0.27 | $-36.35 | |
| Earnings Per Share Basic | $-0.35 | $-0.27 | $-36.35 | |
| Common Stock Shares Issued | 38.5M | 36.7M | 978.2K | 1.4M |
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 30.0M |
| Common Stock Shares Outstanding | 36.6M | 978.2K | 1.4M | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 1.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | |
| Temporary Equity Par Or Stated Value Per Share | $10.20 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | |
| Temporary Equity Shares Outstanding | 4.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 37.1M | 36.2M | 36.2M | 36.2M | 36.4M | 35.5M | 35.2M | 1.1M | 337.3K | 168.8K | 84.0K | 1.4M | 1.4M | 1.3M | 1.0M | 1.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 37.1M | 36.2M | 36.2M | 36.2M | 36.4M | 35.5M | 35.2M | 1.1M | 337.3K | 168.8K | 84.0K | 1.4M | 1.4M | 1.3M | 1.0M | 1.0M | |
| Earnings Per Share Diluted | $-0.13 | $-0.15 | $-0.06 | $-0.09 | $-0.11 | $-0.01 | $-0.03 | $-1.78 | $-8.13 | $-16.33 | $-34.33 | $-0.06 | $-0.02 | $-0.99 | $0.00 | $0.00 | |
| Earnings Per Share Basic | $-0.13 | $-0.15 | $-0.06 | $-0.09 | $-0.11 | $-0.01 | $-0.03 | $-1.78 | $-8.13 | $-16.33 | $-34.33 | $-0.06 | $-0.02 | $-0.99 | $0.00 | $-2.06 | |
| Common Stock Shares Issued | 38.3M | 37.6M | 36.7M | 36.6M | 36.6M | 36.6M | 35.2M | 35.2M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | ||
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | ||
| Common Stock Shares Outstanding | 36.5M | 35.2M | 35.2M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | |||||||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Temporary Equity Par Or Stated Value Per Share | $10.48 | $10.25 | $10.23 | $10.20 | $10.20 | $10.20 | $10.20 | ||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Temporary Equity Shares Outstanding | 910.2K | 910.2K | 4.4M | 4.4M | 4.4M | 4.4M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2022 | FY2021 |
|---|---|---|---|---|
| Additional Paid In Capital | $27.2M | $24.6M | ||
| Stock Issued During Period Value Stock Options Exercised | $12.7K | |||
| Operating Costs And Expenses | $1.4M | $179.0K | ||
| Stock Issued During Period Value New Issues | $2.0M | $25.0K | ||
| Prepaid Expense Current | $137.2K | |||
| Franchise Tax Expense | $201.3K | $70.2K | ||
| Investment Income Interest | $654.1K | $1.4K | ||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $1.8M | $3.0M | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $27.1M | $26.1M | $24.8M | $24.1M | $24.1M | $24.1M | $24.1M | $24.1M | $445.9K | ||||||||
| Stock Issued During Period Value Stock Options Exercised | $12.7K | $525.00 | $525.00 | $525.00 | |||||||||||||
| Operating Costs And Expenses | $155.3K | $136.6K | $523.5K | $399.8K | $120.7K | $10.5K | $3.6K | $819.00 | |||||||||
| Stock Issued During Period Value New Issues | $907.0K | $1.1M | $10.0M | $25.0K | |||||||||||||
| Prepaid Expense Current | $406.1K | $401.2K | $138.8K | $94.7K | $52.5K | $11.6K | $87.0K | $40.5K | $106.4K | $8.0K | |||||||
| Franchise Tax Expense | $13.9K | $13.1K | $25.7K | $24.0K | $24.2K | $97.6K | |||||||||||
| Investment Income Interest | $105.8K | $3.7K | $567.00 | ||||||||||||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $1.8M | $3.0M | |||||||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.2M | $102.4K | $102.4K | $102.4K |
Most recent annual filing with the SEC: March 18, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.